Practices can buy eyelash enhancers from Med Supply Solutions for in-clinic use and practitioner-dispensed home care. The category serves clinics, medical spas, and dermatology practices adding a retail or maintenance layer to aesthetic services they already offer.
Filters
Category
Brand
Price Range
$
$
Global Best Sellers
Buy Eyelash Enhancers Wholesale
Licensed practices can buy eyelash enhancers online at wholesale pricing, with fast shipping and no minimum order on cosmetic lash and brow products including JALUPRO® Enhancer Gel. Practices can purchase eyelash enhancers online for initial stocking or ongoing retail replenishment. Two distinct product classes sit under this heading, and the difference between them governs everything from claims language to patient screening. JALUPRO® Enhancer Gel is a cosmetic conditioning product. Prescription bimatoprost is a pharmaceutical with FDA-approved efficacy for eyelash hypotrichosis and an adverse-effect profile serious enough to require consultation before dispensing.Prescription Products in This Category
Bimatoprost products follow a different pathway. Licensed practices may contact the Med Supply Solutions support team for information about availability, professional requirements, and sourcing considerations.Eyelash Enhancement Products We Carry
JALUPRO® Enhancer Gel
JALUPRO® Enhancer Gel is a cosmetic lash and brow conditioning gel formulated with red clover extract and acetyl tetrapeptide-3. It is intended for practitioner dispensing as a homecare adjunct to in-clinic treatments, and it applies to the brow line as readily as the lash line. The product conditions existing lashes rather than acting pharmacologically on the follicle. That distinction is what keeps it a cosmetic, and what limits the claims a practice may attach to it.Prescription Bimatoprost Products
LUMIGAN® is a prescription ophthalmic solution containing bimatoprost, approved for reducing intraocular pressure in glaucoma and ocular hypertension. The same molecule is marketed as LATISSE®, the only FDA-approved treatment for hypotrichosis of the eyelashes.[1] These are prescription pharmaceuticals rather than cosmetic serums, and the dispensing pathway, patient screening, and consent conversation all differ accordingly. Practices building out a retail aesthetic portfolio commonly stock lash enhancement alongside skincare products. Clinics offering injectable skin treatments often pair it with mesotherapy injections.How Eyelash Enhancers Work
Bimatoprost is a synthetic prostaglandin analogue. It acts on the eyelash hair cycle by extending the anagen phase and increasing the proportion of follicles in active growth, with associated effects on length, thickness, and pigmentation.[1][2] Because lashes cycle through anagen, catagen, and telogen and the growth phase is comparatively short, improvement develops over months rather than weeks. Initial change is typically visible around eight weeks, with fuller results at roughly sixteen weeks of continued use.[1][2] Discontinuation returns lashes to their prior state over subsequent cycles, which makes this a maintenance product rather than a course of treatment. Worth setting that expectation at the point of dispensing, since patients frequently assume the effect persists. Cosmetic products work on a different basis. Rather than altering the growth cycle, formulations such as JALUPRO® Enhancer Gel support the follicular environment and condition existing lashes to improve their appearance. The two are not interchangeable, and cosmetic serums must not be presented as equivalent to prescription bimatoprost in either efficacy or regulatory standing. The cosmetic role is conditioning, which suits patients seeking maintenance without a prescription or without the ocular risk profile.Eyelash Enhancer Safety Profile
Risk differs substantially by product class, and the prescription profile is the one that drives screening. Bimatoprost carries adverse effects that require discussion before treatment begins. Iris hyperpigmentation may occur with prolonged exposure and is permanent.[1] Labeled reactions also include eyelid and periorbital skin darkening, conjunctival hyperemia, ocular pruritus, dry eye symptoms, and eyelid irritation.[1][2] Periorbital fat atrophy can produce a hollowed appearance around the eyes and may not fully resolve after discontinuation.[1] The iris and periorbital changes are the reason bimatoprost sits behind a prescription and a cosmetic serum does not. Both should be raised explicitly rather than folded into a general side-effect list. Bimatoprost warrants caution in patients with active intraocular inflammation, macular edema, aphakia, or known hypersensitivity to any component. It is not indicated below 18 years of age, and use in pregnancy warrants medical evaluation first.[1] Cosmetic lash serums carry a considerably milder profile. Reported effects are limited to transient local irritation, contact dermatitis, and conjunctival irritation following accidental ocular exposure, and use should be discontinued if irritation persists. The milder risk corresponds to a milder effect, and that trade-off is the substance of the conversation at dispensing.Regulatory Status
LATISSE® is the only FDA-approved treatment for hypotrichosis of the eyelashes.[1] LUMIGAN® contains the same active ingredient but holds approval for glaucoma and ocular hypertension, so its use for lash enhancement is off-label. Cosmetic products including JALUPRO® Enhancer Gel are regulated as cosmetics. They may be described as conditioning lashes and brows or improving their appearance, but not as treating hypotrichosis or promoting eyelash growth. The therapeutic claims available to prescription bimatoprost do not transfer to them.FAQs
Do eyelash enhancers really work?
It depends on the product class. Prescription bimatoprost has FDA approval for eyelash hypotrichosis supported by controlled trial evidence.[1][2] Cosmetic serums condition existing lashes and do not carry comparable evidence for growth.What is the difference between LATISSE® and a cosmetic lash serum?
LATISSE® is prescription bimatoprost, FDA-approved for eyelash hypotrichosis.[1] Cosmetic lash serums improve the appearance of existing lashes and carry no approved therapeutic indication.What are the side effects of bimatoprost lash products?
Permanent iris hyperpigmentation, periorbital and eyelid skin darkening, conjunctival hyperemia, dry eye, and periorbital fat atrophy that may not fully reverse after discontinuation.[1]Are eyelash enhancers safe for all patients?
No. Bimatoprost requires assessment and caution in several ocular conditions and is not indicated under 18. Cosmetic serums carry a milder profile but still warrant screening for ingredient sensitivity.How long before results are visible?
With bimatoprost, initial improvement is typically seen around eight weeks and fuller results at approximately sixteen weeks, with continued use required to maintain them.[1][2]Where can licensed professionals buy eyelash enhancers?
Cosmetic products including JALUPRO® Enhancer Gel can be ordered directly from Med Supply Solutions at wholesale pricing. For prescription bimatoprost, licensed practices may contact the Med Supply Solutions support team for information about availability and professional requirements.Citations
[1] LATISSE (bimatoprost ophthalmic solution) 0.03% prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022369s014lbl.pdf [2] Law SK. Bimatoprost in the treatment of eyelash hypotrichosis. Clin Ophthalmol. 2010;4:349-358. Published 2010 Apr 26. doi:10.2147/opth.s6480. https://pubmed.ncbi.nlm.nih.gov/20463804/ For licensed healthcare professionals only. The content of this page is provided for informational purposes and does not constitute medical advice.Best Sellers
Newsletter
Subscribe for exclusive offers and updates on new arrivals
- item.id === nextId);
if(existingIndex !== -1){
toasts.splice(existingIndex, 1);
}
toasts.unshift({
id: nextId,
show: false,
message: event.detail.message,
description: event.detail.description,
type: event.detail.type,
html: event.detail.html,
duration: Number(event.detail.duration || 4000),
persistent: !!event.detail.persistent
});
"
@mouseenter="toastsHovered=true;"
@mouseleave="toastsHovered=false"
x-init="
if(layout == 'expanded'){
expanded = true;
}
stackToasts();
$watch('toastsHovered', function(value){
if(layout == 'default'){
if(position.includes('bottom')){
resetBottom();
} else {
resetTop();
}
if(value){
// calculate the new positions
expanded = true;
if(layout == 'default'){
stackToasts();
}
} else {
if(layout == 'default'){
expanded = false;
setTimeout(function(){
stackToasts();
}, 10)
}
}
}
});
"
class="fixed block w-full group z-99 sm:max-w-lg"
:class="{ 'right-0 top-0 sm:mt-6 sm:mr-6': position=='top-right', 'left-0 top-0 sm:mt-6 sm:ml-6': position=='top-left', 'left-1/2 -translate-x-1/2 top-0 sm:mt-6': position=='top-center', 'right-0 top-0 sm:mr-6 sm:mb-6': position=='bottom-right', 'left-0 bottom-0 sm:ml-6 sm:mb-6': position=='bottom-left', 'left-0 bottom-0 sm:ml-6 sm:mb-6': position=='bottom-center' }"
x-cloak>
-